Patients with AD are more likely to achieve mild disease severity when treated with dupilumab and adjuvant tacrolimus vs dupilumab alone.

Registration is open for the inaugural Atopic Dermatitis Summit. The virtual even will be held on Saturday, April 23, 2022 at 10am EDT.

A new study has shown that internalized skin bias negatively imacts the mental health and QoL of patients with hidradenitis suppurativa.

A pre-clinical comparative study has shown that 1,064 nm lasers may be most effective in tattoo removal.

A new study found difamilast ointment 1% to be safe and efficacious in the treatment of atopic dermatitis.

Psoriasis patients, with and without psoriatic arthritis, self-report using analgesics more than those without the disease.

A new study has shown that clinical response in psoriasis patients treated with ustekinumab tends to vary by anatomical region.

Dupilumab-induced ocular surface disease appears to occur more frequently in patients with AD than with other skin conditions.